Man charged with cyberstalking family member of slain UnitedHealthcare CEO Brian Thompson
Shane Daley, 40, is accused of placing multiple calls to Thompson's family member after the shooting, justifying the killing and saying that the person deserved to die in a similar manner, according to a criminal complaint.
Daley, of Galway, New York, a small town north of Albany, was arrested and had an initial court appearance Wednesday. He was released with GPS monitoring and is scheduled back in court Thursday afternoon, a spokesperson for the U.S. attorney's office in Albany said. Daley's attorney, Samuel Breslin, said they are reviewing the allegations and evidence.
In a statement, Acting United States Attorney John A. Sarcone said that 'Brian Thompson was gunned down in midtown Manhattan. Daley, as alleged, gleefully welcomed this tragedy and did all that he could to increase the Thompson family's pain and suffering.'
Thompson was fatally shot outside a hotel in New York City in December by a man who was angered over what he viewed as corporate greed, according to prosecutors. The suspect, Luigi Mangione, has pleaded not guilty.
The killing of Thompson, who led one of the biggest health insurers in the U.S., resulted in a vast outpouring of public frustration with the country's health care system. Many Americans reacted to the shooting by relaying personal stories about difficult experiences with insurance companies. Mangione himself has been lionized as a sort of vigilante hero by those who are critical of the insurance industry.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Piper Sandler Reiterates a Buy Rating on UnitedHealth Group (UNH)
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best stocks to invest in for beginners. Piper Sandler analyst Jessica Tassan reiterated a Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) on August 5, setting a price target of $280.00. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) reported that its Q2 2025 revenue underwent a $12.8 billion year-over-year growth to $111.6 billion, attributed primarily to growth within Optum and UnitedHealthcare. Earnings from operations for the quarter were $5.2 billion, while adjusted net earnings were $4.08 per share. Management reported a full year 2025 revenue outlook in the $445.5 billion to $448.0 billion range, with a full year 2025 earnings outlook of at least $14.65 per share. UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23 minutes ago
- Yahoo
UFC heavyweight suspended for doping violation
UFC heavyweight suspended for doping violation originally appeared on The Sporting News The UFC career of Alvin Hines is in serious jeopardy. The heavyweight, who lost his Octagon debut at UFC 317 earlier this year, has been suspended for a year after a failed drug test. Hines, who took a bout with Jhonata Diniz on short notice in June, tested positive for the anabolic steroid Drostanolone, the promotion announced. The test results were released by Combat Sports Anti-Doping (CSAD). MORE: Dana White still has trust with Conor McGregor to make big fights A native of Minnesota, Hines was also found to have 3a-Hydroxy-2a-methyl-5a-androstan-17-one and testosterone metabolites, as well as a metabolite of Tamoxifen, 3-Hydroxy-4-methooxytamoxifen, a hormone and metabolic modulator in his system. The tests were take from samples collected both in-competition and out-of-competition. In the release, the UFC noted that the cases reflected that Hines consumed the substances that are banned before he was signed to the UFC, but that he also failed to disclose taking them when his onboarding into the UFC Anti-Doping Program was completed just days before his bout. "Under the UFC ADP, CSAD evaluates each case and can reduce periods of ineligibility based on the athlete's degree of fault and their level of cooperation," the UFC said in a statement. " While Hines failed to disclose his prior use of these substances during onboarding, the estimated concentrations of these substances in Hines' samples were reflective that they were near the tail end of excretion and supported his explanation of their use prior to being signed to the UFC and entering the UFC registered testing pool." The suspension started on July 11, 2025 and runs for one year. MORE COMBAT SPORTS NEWS: PFL sets pair of championship matches for upcoming event How to watch UFC in 2026 on Paramount+ Alexander Volkanovski previews UFC 319 co-main event Complete MMA schedule for 2025
Yahoo
23 minutes ago
- Yahoo
Jim Cramer on UnitedHealth: 'It Could Come Back'
UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks Jim Cramer shed light on. Cramer showed a slight bit of optimism toward the company as he said: 'I think UnitedHealth's going to work here… I think it's going to work. I really do. Look, I'm not a believer. I don't like the fact that they had shenanigans, but I will say this: I think that the company is run by a very good CEO. It could come back.' Ken Wolter/ UnitedHealth Group Incorporated (NYSE:UNH) provides health benefits, pharmacy care, care delivery, and health management services. In addition, the company offers data analytics and technology-driven solutions for individuals, employers, governments, and health systems. During the August 7 episode, when a caller inquired about the company stock, Cramer responded: 'I have long known, this is something I learned probably in my second decade of trading or investing: You do not buy or sell something where you have no idea what is really happening. And at UnitedHealth, there isn't anyone other than the CEO and probably 52,000 lawyers who has any idea what's going on.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos
